The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sunday newspaper round-up: Brexit, Coronavirus, AstraZeneca

Sun, 13th Dec 2020 18:57

(Sharecast News) - Britain and the EU have taken a step forward towards striking a post-Brexit trade and security deal after Boris Johnson and Ursula von der Leyen agreed to "go the extra mile" and ordered the resumption of talks in Brussels. The prime minister played down expectations following the telephone conversation with the European commission president, telling the cabinet to prepare for a no-deal exit when the transition period ends in three weeks' time. But in Brussels, EU embassies were briefed by the commission that "progress has been made" and that "the next days will be important". - Guardian

Britain could be "back to normal" by summer as long as it avoids a third wave after Christmas, the British scientist behind a Covid vaccine has said. Professor Sarah Gilbert, the lead researcher on the Oxford vaccine, said "people's behaviour in the coming weeks is going to have a big impact" on when facemasks and social distancing requirements can be dropped. She said that a spike in coronavirus cases in January would disrupt vaccination programmes. - Sunday Times

Britain's biggest maker of pharmaceuticals has swooped on an American rival in a daring move on the eve of Brexit. Astra Zeneca, the FTSE 100 drug-maker playing a central role in the fight against Covid-19, has agreed to buy Alexion Pharmaceuticals for $39bn (£28.9bn). The cash-and-shares deal will cement the Anglo-Swedish giant's position in immunology and give it a dedicated rare disease business based in Boston, Massachusetts. - Sunday Times

Keith Williams is a man of many modes of transport. The corporate veteran spent 18 years at airline British Airways - the final five as chief executive and chairman - and will in the New Year publish his long-awaited review into the rail industry. Now he is the boss of Royal Mail - and drones are firmly on his radar. Williams wants to use the unmanned vehicles to fly letters to remote areas in the UK. 'If you take, say, the Scilly Isles - an expensive piece of water [to cross] - they might be ideally suited to a drone,' he says. - Mail on Sunday

More Leave voters than Remainers have swung from the Tories to Labour since the last election, according to a major polling project that suggests Keir Starmer, the Labour leader, has made some early progress in bridging the Brexit divide. A large 7,000-strong poll, designed to examine the political changes that have taken place since Labour's disastrous result, found that the party was showing signs of winning over some of those who backed the Tories last year. - Guardian

Giant American fashion and investment corporations are eyeing up bids for Topshop and its parent group Arcadia. [...] Around 30 to 40 potential buyers are believed to have shown initial interest and have received a limited information pack on the business from Arcadia's administrators, Deloitte. First-round bids are due in by the end of this week. - Mail on Sunday

A French satellite giant is muscling in on Britain's broadband market by targeting half a million people in the remotest parts of the nation. Eutelsat has launched Konnect, a satellite broadband service for homes that will not benefit from industry efforts to carpet Britain in gigabit speed connectivity. The service was rolled-out in the UK last week ahead of expanding across Europe and parts of Africa using the same satellite infrastructure. - Sunday Telegraph

Mike Ashley is racing to complete a deal to buy Debenhams this weekend, sources have told The Mail on Sunday. The sportswear mogul is in talks to buy the £500million web business - to help him crack the high-end cosmetics market - but the Debenhams store chain has been vastly slimmed down. 'There's very little time left to rescue the business,' said one City source. 'But without at least 30 or 40 of the 124Nightcap stores, this might not look very much like a rescue at all.' - Mail on Sunday

Dragons' Den entrepreneur Sarah Willingham is preparing to float a chain of city-centre bars with a team including celebrity chef Raymond Blanc, despite the malaise gripping leisure. Willingham, 46, has agreed a counterintuitive deal to buy London Cocktail Club through a stock market listing of her investment vehicle, Nightcap, on AIM in the coming weeks. She plans to raise £6m at a valuation of £14m. - Sunday Times



More News
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.